Vertiv Holdings Co — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Vertiv Holdings Co filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | Mar 12, 2020 |
| FY2019 | Dec 31, 2018 | $0 | Mar 12, 2020 |
| FY2019 | Dec 31, 2017 | $0 | Mar 12, 2020 |
| FY2018 | Dec 31, 2016 | $0 | Mar 13, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.23B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $8.01B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $6.86B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $5.69B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $5.00B | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $1.31B | Apr 30, 2021 |
| FY2020 | Sep 30, 2020 | $1.16B | Apr 30, 2021 |
| FY2020 | Jun 30, 2020 | $1.01B | Apr 30, 2021 |
| FY2020 | Mar 31, 2020 | $897.30M | Apr 30, 2021 |
| FY2020 | Dec 31, 2019 | $1.17B | Apr 30, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.33B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $495.80M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $460.20M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $76.60M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $119.60M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $40.50M | Apr 30, 2021 |
| FY2020 | Sep 30, 2020 | ($103.50M) | Apr 30, 2021 |
| FY2020 | Jun 30, 2020 | ($56.00M) | Apr 30, 2021 |
| FY2020 | Mar 31, 2020 | ($208.30M) | Apr 30, 2021 |
| FY2020 | Dec 31, 2019 | ($33.90M) | Apr 30, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.83B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.37B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $872.20M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $223.40M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $259.90M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $213.50M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $206.10M | Mar 1, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $441.70M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $367.60M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $303.50M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $282.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $266.40M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $228.60M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $229.40M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $198.30M | Apr 30, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.62B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.37B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.31B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.18B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.11B | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $265.50M | Apr 30, 2021 |
| FY2020 | Sep 30, 2020 | $251.70M | Apr 30, 2021 |
| FY2020 | Jun 30, 2020 | $226.30M | Apr 30, 2021 |
| FY2020 | Mar 31, 2020 | $264.80M | Apr 30, 2021 |
| FY2020 | Dec 31, 2019 | $291.80M | Apr 30, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.11B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.32B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $900.50M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | ($152.80M) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $210.90M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $208.90M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $57.50M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | ($221.90M) | Apr 30, 2021 |
| FY2018 | Dec 31, 2016 | ($25.0K) | Mar 13, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $220.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $167.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $127.90M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $100.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $73.40M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $44.40M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $47.60M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $64.60M | Apr 30, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.21B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $9.13B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $8.00B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $7.10B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $6.94B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $5.07B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $4.66B | Apr 30, 2021 |
| FY2019 | Dec 31, 2018 | $697.34M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $25.0K | Mar 13, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.27B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $6.70B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $5.98B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $5.65B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $5.52B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $4.56B | Mar 1, 2022 |
| FY2020 | Sep 30, 2020 | $4.63B | Apr 30, 2021 |
| FY2020 | Jun 30, 2020 | $4.52B | Apr 30, 2021 |
| FY2020 | Mar 31, 2020 | $4.35B | Apr 30, 2021 |
| FY2020 | Dec 31, 2019 | $5.36B | Apr 30, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.94B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $2.43B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $2.01B | Feb 13, 2026 |
| FY2025 | Dec 31, 2022 | $1.44B | Feb 13, 2026 |
| FY2024 | Dec 31, 2021 | $1.42B | Feb 18, 2025 |
| FY2023 | Dec 31, 2020 | $512.10M | Feb 23, 2024 |
| FY2020 | Sep 30, 2020 | $146.10M | Apr 30, 2021 |
| FY2020 | Jun 30, 2020 | $213.00M | Apr 30, 2021 |
| FY2020 | Mar 31, 2020 | $276.20M | Apr 30, 2021 |
| FY2022 | Dec 31, 2019 | ($704.80M) | Feb 27, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.03B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.32B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.33B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.28B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.33B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $607.20M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $605.80M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $634.00M | Apr 30, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.03B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | ($238.30M) | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | ($691.90M) | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | ($1.14B) | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | ($1.22B) | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | ($1.33B) | Mar 1, 2022 |
| FY2020 | Sep 30, 2020 | ($1.37B) | Apr 30, 2021 |
| FY2020 | Jun 30, 2020 | ($1.26B) | Apr 30, 2021 |
| FY2020 | Mar 31, 2020 | ($1.21B) | Apr 30, 2021 |
| FY2020 | Dec 31, 2019 | ($1.00B) | Apr 30, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.73B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.23B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $780.40M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $260.60M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $439.10M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $534.60M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $223.50M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $215.10M | Apr 30, 2021 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.91B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $2.93B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $2.94B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $3.19B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $2.97B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $2.15B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $3.47B | Apr 30, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Apr 30, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Apr 30, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Apr 30, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Apr 30, 2021 |
| FY2021 | Dec 31, 2019 | (1) | Mar 1, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Apr 30, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Apr 30, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Apr 30, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Apr 30, 2021 |
| FY2021 | Dec 31, 2019 | (1) | Mar 1, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 382.55M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 380.70M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | 381.79M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | 377.37M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 375.80M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | 342.02M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 118.26M | Apr 30, 2021 |